Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP716835.RAy4pBJLoBzvXYlKwdxqkwTNi7Y4ykAvBbxp1z28-f23E130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP716835.RAy4pBJLoBzvXYlKwdxqkwTNi7Y4ykAvBbxp1z28-f23E130_assertion type Assertion NP716835.RAy4pBJLoBzvXYlKwdxqkwTNi7Y4ykAvBbxp1z28-f23E130_head.
- NP716835.RAy4pBJLoBzvXYlKwdxqkwTNi7Y4ykAvBbxp1z28-f23E130_assertion description "[Primary plasma cell leukemia (pPCL) is a rare, yet aggressive form of de novo plasma cell tumor, distinct from secondary PCL (sPCL) which represents a leukemic transformation of pre-existing multiple myeloma (MM).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP716835.RAy4pBJLoBzvXYlKwdxqkwTNi7Y4ykAvBbxp1z28-f23E130_provenance.
- NP716835.RAy4pBJLoBzvXYlKwdxqkwTNi7Y4ykAvBbxp1z28-f23E130_assertion evidence source_evidence_literature NP716835.RAy4pBJLoBzvXYlKwdxqkwTNi7Y4ykAvBbxp1z28-f23E130_provenance.
- NP716835.RAy4pBJLoBzvXYlKwdxqkwTNi7Y4ykAvBbxp1z28-f23E130_assertion SIO_000772 23044976 NP716835.RAy4pBJLoBzvXYlKwdxqkwTNi7Y4ykAvBbxp1z28-f23E130_provenance.
- NP716835.RAy4pBJLoBzvXYlKwdxqkwTNi7Y4ykAvBbxp1z28-f23E130_assertion wasDerivedFrom befree-20140225 NP716835.RAy4pBJLoBzvXYlKwdxqkwTNi7Y4ykAvBbxp1z28-f23E130_provenance.
- NP716835.RAy4pBJLoBzvXYlKwdxqkwTNi7Y4ykAvBbxp1z28-f23E130_assertion wasGeneratedBy ECO_0000203 NP716835.RAy4pBJLoBzvXYlKwdxqkwTNi7Y4ykAvBbxp1z28-f23E130_provenance.